Skip to main content
. 2022 Mar 1;13:1100. doi: 10.1038/s41467-022-28705-x

Fig. 7. UHMK1 requires a functional kinase and UHM domain to regulate the BRAFi response.

Fig. 7

UHMK1 was genetically inactivated in A375 cells using CRISPR-Cas9, and the MSCV-GFP vector was stably expressed in A375-Cas9 and A375-UHMK1-gRNA cells. UHMK1-V5, UHMK1-K54R-V5, and UHMK1-RNP1-mut-V5 (R369A-G370A-Q-V-F372A) were ectopically expressed in A375-UHMK1-gRNA cells. a RNA immunoprecipitation (RNA-IP) assays were performed in the indicated cell lines following treatment with DMSO or 1 μM Vem for 48 hr. The indicated mRNA transcripts were then analysed using RT-qPCR. Data represent mean ± SEM of n = 3 biologically independent experiments. b Sensitivity to Vem was assessed using dose-response assays and 50% growth inhibition (GI50) drug concentrations were calculated. Data represent mean ± SEM of n = 3 biologically independent experiments. Statistical significance was determined using a one-way ANOVA adjusted for multiple comparisons. Source data are provided as a Source Data file.